Wednesday 4th June 2025 |
Text too small? |
Rua Bioscience advises that it has reached a settlement with Cann Group Limited (ASX:CAN), following legal proceedings initiated by Rua in February 2024.
As part of the legal proceedings, both parties undertook mediation which had led to this settlement. Rua Bioscience and Cann Group have executed new supply agreements to support their respective operations in the New Zealand and Australian medicinal cannabis markets. The commercial terms of the settlement are confidential and take effect immediately.
ENDS
No comments yet
Fonterra reports continued strong performance in FY25
Air NZ issues Australian $300 million Medium Term Notes
KMD - FY25 Annual Results Announcement
Tower successfully renews insurance programme for FY26
September 24th Morning Report
AIA - Auckland Airport considers bond offers
September 22nd Morning Report
September 19th Morning Report
Smartpay Scheme Booklet and Notice of Meeting
September 18th Morning Report